Amy Schacterle insider trades
Open-market stock purchases and sales by Amy Schacterle, Chief Regulatory Officer at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 5, 2024.
Companies traded
- ABOS Acumen Pharmaceuticals, Inc: 1 sale, last Jan 16, 2026